Ready to play
Ready to play
Scientists at Vanderbilt University in the United States have developed an experimental artificial lens that treats two eye conditions: cataracts and glaucoma. This is achieved by combining the replacement of the cloudy lens with the gradual release of a medication that lowers intraocular pressure. Experiments have shown that over 95% of patients who received the implants did not need additional medications after a year, while maintaining eye pressure levels similar to those managed with daily eye drops. The technology aims to simplify the treatment of these two conditions through a single procedure and reduce the ongoing need for eye drops.
Notice: This Is an AI-Generated Summary
Comments (0)